Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
June 2026’s crypto rout erased about $62 billion in market value from public firms with Bitcoin on the balance sheet,...
KB Home accelerated its land replenishment in 2024, then signaled a slower pace in 2025. The shift could influence wh...
A new Xbox CEO rises amid a changing gaming landscape. Her career path—from janitorial work to coupon sales to the C-...
Stylecraft Builders maintains momentum in Texas by deploying a precise, micro approach to margins and pace. With 2025...
New American Funding is expanding its reverse mortgage team to turn home equity into a core retirement tool, led by S...
McDonald’s brings back its fried apple pie for America’s semiquincentennial, a limited-time move that fuses nostalgia...
Niche energy tech stocks can surge on fresh coverage and bullish notes. This guide explains why the nano nuclear ener...
Tesla posted solid Q1 2026 results but CEO Elon Musk tempered enthusiasm for Optimus and the Robotaxi, signaling grad...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
Retirement isn’t just about money—it’s about meaning. Discover how to win the retirement game: connect socially with ...